CTOs on the Move

GenMark Diagnostics

www.genmarkdx.com

 
In 1993, a novel technology was invented by a team that included Jon Faiz Kayyem, PhD at The California Institute of Technology (CalTech). This invention combined nucleic acids and microelectronics to produce an electronic sensor for DNA detection. His invention was based on electrical detection of nucleic acids on a cassette based detection platform. Dr. Kayyem went on to found Clinical Micro Sensors, with the goal of translating this “eSensor” technology to disposable chips. Following several acquisitions of the technology, Dr. Kayyem became actively involved again in 2009, returning as an investor and then as CEO and Chairman of the ...
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.genmarkdx.com
  • 5964 La Place Court Suite 100
    Carlsbad, CA USA 92008
  • Phone: 760.448.4300

Executives

Name Title Contact Details

Similar Companies

BioVentrix

BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA.

Sandhill Scientific

Sandhill Scientific is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Beaverstate Dental Inc

Beaverstate Dental Inc is a Newberg, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pacific Coast Medical Svc

Pacific Coast Medical Svc is a Anaheim, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Palette Life Sciences

Palette Life Sciences is a fully integrated medical device company providing a wide range of products and services that improve quality of life of patients. Our portfolio of products focuses on treating conditions in urology/urogynecology disorders, colorectal conditions, radiotherapy, and interventional oncology procedures. For physicians, researchers, and inventors alike, progress begins with a natural curiosity and the drive to do more. By discovering and applying new applications of proven medicine to uncommon, or difficult to treat conditions, we can address the needs of patients often overlooked by traditional medical companies. Inspired by innovation and empathy, we see endless possibilities in expanding on proven technologies to elevate patient care. The foundation for all of our breakthrough products is Non-Animal Stabilized Hyaluronic Acid (NASHA®). NASHA has been proven safe and effective for more than two decades in over 50 million medical procedures worldwide. Barrigel® - the first and only FDA-cleared hyaluronic acid rectal spacer, minimizing the side effects of radiation therapy for prostate cancer patients. Barrigel is available in the US, Australia and Europe. Deflux® - the only FDA-approved injectable treatment for vesicoureteral reflux (VUR), a urinary defect that affects 1% of children worldwide. Deflux for VUR is available in the US, Canada, Europe, Japan, Latin America, Australia and New Zealand. Also indicated for stress urinary incontinence (SUI) in women, Deflux for SUI is available in Canada and Europe.